<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03868982</url>
  </required_header>
  <id_info>
    <org_study_id>PL-201808006-V</org_study_id>
    <nct_id>NCT03868982</nct_id>
  </id_info>
  <brief_title>Lung Protection in ARDS Using Neurally Adjusted Ventilatory Assist</brief_title>
  <acronym>NAVA</acronym>
  <official_title>Lung Protection in Acute Respiratory Distress Syndrome Using Neurally Adjusted Ventilatory Assist</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fu Jen Catholic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fu Jen Catholic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the use neurally adjusted ventilatory assist (NAVA)
      as lung protective strategy in patients with acute respiratory distress syndrome (ARDS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background： Acute respiratory distress syndrome (ARDS) should ventilated with a tidal volume
      of 4-6 ml/kg according to the ARDSnet recommendations. Due to the lack of clinical evidence
      of the potential role of neurally adjusted ventilatory assist (NAVA) in ARDS, investigators
      would like to conduct a study comparing the two modes from a lung protective point of view.
      Investigators believe it may have a great value in defining guidelines for improved lung
      protection.

      Study Design： This is a prospective, pilot-randomized controlled trial n a single intensive
      care unit from one hospital. The study is expected to close the case a year
      (2018.08.01-2019.07.31).

      Methods： Fifty patients with ARDS according to the Berlin Definition will enroll to this
      study. Patients are randomized after fulfilling inclusion and none of the exclusion criteria
      (25 participants will divide into study group and the other 25 participants will be control
      group). Patients are studied twice daily with collection of data and blood tests. All data
      are collected and analysis.

      Effect： Tidal volumes in ARDS patients ventilated with NAVA will show tidal volumes clearly
      within the safe range. ARDS patients on NAVA mode will show improvements in oxygenation, gas
      distribution and inflammatory markers while requiring less sedatives and hemodynamic support.

      Key words： Acute respiratory distress syndrome; neurally adjusted ventilatory assist; lung
      protective strategy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 18, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Fifty participant with ARDS according to the Berlin Definition will enroll to this study. Participants studied twice daily with collection of data and blood tests.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants will be randomized into study group or control group, and which is single blind processes to participants.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>PaO2/FiO2 ratio</measure>
    <time_frame>2 days</time_frame>
    <description>PaO2 is a data from ABG; FiO2 is the data of ventilator deliver oxygen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PaCO2</measure>
    <time_frame>2 days</time_frame>
    <description>PaCO2 is a data from ABG, represent in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tidal volume</measure>
    <time_frame>2 days</time_frame>
    <description>Tidal volume is represent in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation days</measure>
    <time_frame>3 months</time_frame>
    <description>MV days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>3 months</time_frame>
    <description>hospital days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of intensive care unit stay</measure>
    <time_frame>3 months</time_frame>
    <description>ICU days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>ARDS, Human</condition>
  <condition>Mechanical Ventilation Pressure High</condition>
  <arm_group>
    <arm_group_label>NAVA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participent in this group will received NAVA for two days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participent in this group will received standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neurally adjusted ventilatory assist</intervention_name>
    <description>NAVA uses the diaphragm activity to deliver mechanical ventilation</description>
    <arm_group_label>NAVA group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of ARDS by Berlin definition

          -  P/F ratio between 100-300

          -  Completed the case enrollement within 48 hours

        Exclusion Criteria:

          -  Less than 18 years old

          -  Pregnancy

          -  Participants with tracheostomy

          -  Unable to insert the NG-tube
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wen-Lun Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Emergency and Critical Care Medicine, Fu Jen Catholic University Hospital, Fu Jen Catholic University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ke-Yun Chao, M.Sc</last_name>
    <phone>+886952909103</phone>
    <email>ck_qq@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fu Jen Catholic University Hospital, Fu Jen Catholic University</name>
      <address>
        <city>New Taipei City</city>
        <zip>24352</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ke-Yun Chao, M.Sc</last_name>
      <phone>+886952909103</phone>
      <email>ck_qq@hotmail.con</email>
    </contact>
    <investigator>
      <last_name>Ke-Yun Chao, M.Sc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Navalesi P, Colombo D, Della Corte F. NAVA ventilation. Minerva Anestesiol. 2010 May;76(5):346-52. Review.</citation>
    <PMID>20395897</PMID>
  </reference>
  <reference>
    <citation>Bourenne J, Guervilly C, Mechati M, Hraiech S, Fraisse M, Bisbal M, Roch A, Forel JM, Papazian L, Gainnier M. Variability of reverse triggering in deeply sedated ARDS patients. Intensive Care Med. 2019 May;45(5):725-726. doi: 10.1007/s00134-018-5500-6. Epub 2019 Feb 28.</citation>
    <PMID>30820583</PMID>
  </reference>
  <reference>
    <citation>Assy J, Mauriat P, Tafer N, Soulier S, El Rassi I. Neurally adjusted ventilatory assist for children on veno-venous ECMO. J Artif Organs. 2019 Jun;22(2):118-125. doi: 10.1007/s10047-018-01087-y. Epub 2019 Jan 4.</citation>
    <PMID>30610519</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>March 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2019</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fu Jen Catholic University</investigator_affiliation>
    <investigator_full_name>Ke-Yun, Chao</investigator_full_name>
    <investigator_title>Group leader of Respiratory Therapists</investigator_title>
  </responsible_party>
  <keyword>acute respiratory distress syndrome</keyword>
  <keyword>neurally adjusted ventilatory assist</keyword>
  <keyword>lung protective strategy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

